Concepedia

Xingling Zheng

XZ

Statistics

Publications

14

Citations

1.1K

H-Index

12

Active since

2017

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

Shanghai Jiao Tong University

Shanghai Cancer Institute

Xingling Zheng is an author at Shanghai Institute of Materia Medica specializing in oncology, molecular oncology, and medicine.

Publications per year

2017–2025

14

Publications

14

EGFR activation limits the response of liver cancer to lenvatinib

Haojie Jin, Yuanyuan Lv, Shengxian Yuan et al. · Nature · 2021 · 432 citations

Medicine, Oncology, Pharmacology +14

Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors

Xun Huang, Juan Yan, Min Zhang et al. · Cell · 2018 · 271 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

CTC clusters induced by heparanase enhance breast cancer metastasis

Rongrui Wei, Danni Sun, Hong Yang et al. · Acta Pharmacologica Sinica · 2018 · 105 citations

Medicine, Cancer Biology, Oncology +14

cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis

Liqin Wang, Haojie Jin, Fleur Jochems et al. · Nature Cancer · 2022 · 60 citations

Life Sciences, Cell Biology, Oncology +16

Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition

Danni Sun, Hong‐Chun Liu, Xiaoyang Dai et al. · Cancer Letters · 2017 · 39 citations

Medicine, Oncology, Pharmacology +14

1–5 of 14